Plain-English translation of NCT07705334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing , a new type of cancer medication taken by mouth once daily. Researchers want to find the right dose and learn whether this medication is safe and can help people with advanced cancers that have stopped responding to standard treatments. The trial will enroll about 30 people across multiple centers.
Many people with advanced cancers run out of treatment options when standard therapies stop working or cause too many side effects. This medication represents a new approach that might help these patients, but researchers need to first test whether it is safe and effective in humans.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth once every day. The trial has two phases: in the first phase, researchers gradually increase the dose in small groups of patients to find the safest and most effective dose; in the second phase, larger groups of patients with specific cancer types will receive the medication at the dose identified as best. You will have regular visits for blood tests, imaging scans, and biopsies to monitor how your body responds and whether the cancer is shrinking.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States